INTRUST BANK NA - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 887 filers reported holding GLAXOSMITHKLINE PLC in Q4 2019. The put-call ratio across all filers is 0.83 and the average weighting 0.3%.

Quarter-by-quarter ownership
INTRUST BANK NA ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q3 2020$272,000
+34.0%
7,234
+67.3%
0.05%
+4.3%
Q4 2019$203,000
-6.0%
4,325
-19.7%
0.05%
-16.4%
Q3 2018$216,000
-1.8%
5,387
-1.4%
0.06%
-9.8%
Q2 2018$220,000
+1.4%
5,462
+2.2%
0.06%
-14.1%
Q3 2017$217,000
-4.0%
5,346
+1.6%
0.07%
-7.8%
Q2 2017$226,000
-3.4%
5,263
-5.3%
0.08%
-7.2%
Q1 2017$234,000
+13.6%
5,557
+4.0%
0.08%
+6.4%
Q4 2016$206,000
-46.9%
5,344
-40.5%
0.08%
-49.7%
Q3 2016$388,000
-6.5%
8,981
-6.1%
0.16%
-7.2%
Q2 2016$415,000
+4.3%
9,568
-2.5%
0.17%
+16.8%
Q1 2016$398,000
-5.7%
9,816
-6.3%
0.14%
-9.5%
Q4 2015$422,000
-5.6%
10,475
-9.9%
0.16%
-7.1%
Q3 2015$447,000
+3.7%
11,632
+12.5%
0.17%
+13.3%
Q2 2015$431,000
-10.0%
10,337
-0.3%
0.15%
-11.2%
Q1 2015$479,000
+6.7%
10,372
-1.2%
0.17%
+1.2%
Q4 2014$449,000
-14.8%
10,496
-8.5%
0.17%
-18.1%
Q3 2014$527,000
-9.8%
11,468
+5.1%
0.20%
-6.4%
Q2 2014$584,000
+4.1%
10,915
+4.0%
0.22%
-5.6%
Q1 2014$561,000
-7.7%
10,498
-7.8%
0.23%
-12.8%
Q4 2013$608,000
+9.0%
11,390
+2.4%
0.26%
-1.5%
Q3 2013$558,000
-12.3%
11,124
-12.5%
0.27%
-4.6%
Q2 2013$636,00012,7140.28%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q4 2019
NameSharesValueWeighting ↓
Black Creek Investment Management Inc. 7,951,626$318,224,00010.49%
Healthcare Value Capital, LLC 120,000$4,802,0009.01%
KAHN BROTHERS GROUP INC 1,605,014$64,232,661,0008.03%
Eversept Partners, LP 693,685$28,091,8907.87%
EQUITY INVESTMENT CORP 2,673,764$107,004,0003.74%
Sio Capital Management, LLC 379,500$15,188,0003.66%
Martin Capital Partners, LLC 115,448$4,620,0003.27%
Circle Road Advisors LP 53,028$2,122,0003.10%
Keystone Financial Planning, Inc. 156,968$6,282,0003.07%
CAMG Solamere Management, LLC 160,294$6,415,0002.94%
View complete list of GLAXOSMITHKLINE PLC shareholders